Your browser doesn't support javascript.
loading
Survival Outcomes in Older Adult Acute Lymphoblastic Leukemia Patients Analyzed by Facility Volume and Type: A National Cancer Database Analysis.
Dykes, Kaitlyn C; Chou, Jiling; Taylor, Allison O; Shu, Albert C; Mudra, Sarah E; Ma, Xiaoyang; Ahn, Jaeil; Lai, Catherine E.
Afiliação
  • Dykes KC; Department of Medicine, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Chou J; Department of Medicine, Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, San Diego, California, USA.
  • Taylor AO; Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC, USA.
  • Shu AC; Department of Medicine, Division of Hematologic Malignancies & Cellular Therapy, Duke Cancer Institute, Durham, North Carolina, USA.
  • Mudra SE; Department of Medicine, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Ma X; Department of Medicine, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Ahn J; Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC, USA.
  • Lai CE; Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC, USA.
Cancer Rep (Hoboken) ; 7(8): e2162, 2024 Aug.
Article em Es | MEDLINE | ID: mdl-39118243
ABSTRACT
BAKGROUND It is important to understand the outcomes of adult acute lymphoblastic leukemia (ALL) patients at different facilities as treatment paradigms change.

AIMS:

Our primary objective was to determine adult ALL overall survival (OS) by facility volume and type. Secondary objectives included identifying sociodemographic factors that may have impacted outcomes and analyzing treatment patterns by facility volume and type.

METHODS:

This was a retrospective analysis of the National Cancer Database (NCDB) that included patients ≥40 years diagnosed with ALL between 2004 and 2016.

RESULTS:

A total of 14 593 patients were included in this study. Univariate OS was greatest at low volume (LV) and community programs (CPs) and the least at high volume (HV) and academic programs (AP). This difference was lost after multivariable Cox proportional hazards model analysis, which found no difference in survival by facility volume or type, however, survival was significantly influenced by age, race, Hispanic ethnicity, insurance, and residence location (p < 0.05). Patients treated at HV and APs compared to LV and CP received more anti-neoplastic directed therapy.

CONCLUSION:

Our results suggest treatment facility volume and type do not impact older adult ALL patient (≥40 years) survival, however confounding sociodemographic differences do impact survival outcomes, despite more aggressive and novel treatment approaches provided at HV and APs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bases de Dados Factuais / Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: Es Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bases de Dados Factuais / Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: Es Ano de publicação: 2024 Tipo de documento: Article